Honda is recalling 440,830 Honda Odysseys from 2018 to 2022. The vehicles are being recalled for a software programming ...
STORM Therapeutics, a Cambridge-based clinical stage company targeting RNA modifications to reprogram cells and develop novel ...
The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indications· First‑in‑class METTL3 inhibitor reprograms malignant progenitor cells by ...
Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in ...
A study shows aggressive lymphomas trigger inflammatory signals that reprogram stromal cells, disrupting lymph node structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results